MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Topical steroid withdrawal syndrome may signal a reminder to clinicians to be good stewards of topical treatments, according ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...